abstract |
The present invention relates to 4-epi-isofagomine enantiomer derivatives, pharmaceutically acceptable salts thereof, and the use of said 4-epi-isofagomine enantiomer derivatives in the treatment and/or prevention of lysosomal storage diseases. The present invention is furthermore related to processes for their preparation. |